Highlighting bipolar II disorder

Canadian Journal of Psychiatry

Volumn 49, Issue 12, 2004, Pages 791-793

  Parker, Gordon ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BLACK DOG INSTITUTE   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR DISORDER; CLINICAL FEATURE; CONCEPT FORMATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; EDITORIAL; HUMAN; MEDICAL LITERATURE; MENTAL HEALTH CARE; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PUBLICATION;

EID: 12744271880     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370404901201     Document Type: Editorial

References (15)

1. McGrath BM, Wessels P, Bell EC, Ulrich M, Silverstone PH. Neurobiological findings in bipolar 11 disorder compared with those in bipolar 1 disorder. Can J Psychiatry 2004;49:794-801.
2. Hadjipavlou G, Mok H, Yatham LN. Bipolar II disorder: an overview of recent developments. Can J Psychiatry 2004;49:802-12.
3. Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-58.
4. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, and others. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
5. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998;50:143-51.
6. Hibbeln JR. Fish consumption and major depression. Lancet 1998;351:1213.
7. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2001;69:15-29.
8. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, and others. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-12.
9. Nemets B, Stahl Z, Belmaker RH. Addition of Omega-3 Fatty Acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-9.
10. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with depression despite adequate treatment with standard drugs. Arch Gen Psychiatry 2002;59:913-9.
11. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998;48:149-55.
12. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered Omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999;85:275-91.
13. Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, and others. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003;60:145-52.
14. Parker G, Parker K. Which antidepressants flick the switch? A review. Aust N Z J Psychiatry 2003;37:464-8.
15. Parker G. Do the newer antidepressants have mood stabilizing properties? [letter]. Aust N Z J Psychiatry 2002;36:427-8.